Synonymous Substitution Rates Predict HIV Disease Progression as a Result of Underlying Replication Dynamics

Upon HIV transmission, some patients develop AIDS in only a few months, while others remain disease free for 20 or more years. This variation in the rate of disease progression is poorly understood and has been attributed to host genetics, host immune responses, co-infection, viral genetics, and adaptation. Here, we develop a new “relaxed-clock” phylogenetic method to estimate absolute rates of synonymous and nonsynonymous substitution through time. We identify an unexpected association between the synonymous substitution rate of HIV and disease progression parameters. Since immune activation is the major determinant of HIV disease progression, we propose that this process can also determine viral generation times, by creating favourable conditions for HIV replication. These conclusions may apply more generally to HIV evolution, since we also observed an overall low synonymous substitution rate for HIV-2, which is known to be less pathogenic than HIV-1 and capable of tempering the detrimental effects of immune activation. Humoral immune responses, on the other hand, are the major determinant of nonsynonymous rate changes through time in the envelope gene, and our relaxed-clock estimates support a decrease in selective pressure as a consequence of immune system collapse.

[1]  Hui Li,et al.  Nef-Mediated Suppression of T Cell Activation Was Lost in a Lentiviral Lineage that Gave Rise to HIV-1 , 2006, Cell.

[2]  Sergei L. Kosakovsky Pond,et al.  Adaptation to Different Human Populations by HIV-1 Revealed by Codon-Based Analyses , 2006, PLoS Comput. Biol..

[3]  Martin Meier-Schellersheim,et al.  CD4 T Cell Depletion Is Linked Directly to Immune Activation in the Pathogenesis of HIV-1 and HIV-2 but Only Indirectly to the Viral Load1 , 2002, The Journal of Immunology.

[4]  J. Margolick,et al.  Influence of Random Genetic Drift on Human Immunodeficiency Virus Type 1 env Evolution During Chronic Infection , 2004, Genetics.

[5]  B. Walker,et al.  Fitness Cost of Escape Mutations in p24 Gag in Association with Control of Human Immunodeficiency Virus Type 1 , 2006, Journal of Virology.

[6]  Hirohisa Kishino,et al.  Estimating absolute rates of synonymous and nonsynonymous nucleotide substitution in order to characterize natural selection and date species divergences. , 2004, Molecular biology and evolution.

[7]  O. Pybus,et al.  Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.

[8]  I Quinti,et al.  Antibodies mediating cellular cytotoxicity and neutralization correlate with a better clinical stage in children born to human immunodeficiency virus-infected mothers. , 1990, The Journal of infectious diseases.

[9]  C Chappey,et al.  First case of mother-to-infant HIV type 1 group O transmission and evolution of C2V3 sequences in the infected child. French HIV Pediatric Cohort Study Group. , 1998, AIDS research and human retroviruses.

[10]  Becca Asquith,et al.  Inefficient Cytotoxic T Lymphocyte–Mediated Killing of HIV-1–Infected Cells In Vivo , 2006, PLoS biology.

[11]  J V Giorgi,et al.  Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. , 1999, The Journal of infectious diseases.

[12]  James Theiler,et al.  Advantage of rare HLA supertype in HIV disease progression , 2003, Nature Medicine.

[13]  Martin Meier-Schellersheim,et al.  Pathogenesis of HIV infection: what the virus spares is as important as what it destroys , 2006, Nature Medicine.

[14]  D. Ho,et al.  Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome , 1994, Journal of virology.

[15]  S. Ho,et al.  Relaxed Phylogenetics and Dating with Confidence , 2006, PLoS biology.

[16]  M P Dempsey,et al.  Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. , 1991, Science.

[17]  D. Strick,et al.  Comprehensive Epitope Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific T-Cell Responses Directed against the Entire Expressed HIV-1 Genome Demonstrate Broadly Directed Responses, but No Correlation to Viral Load , 2003, Journal of Virology.

[18]  A Muñoz,et al.  A longitudinal study of neutralizing antibodies and disease progression in HIV-1-infected subjects. , 1999, The Journal of infectious diseases.

[19]  C. Bustamante,et al.  A statistical characterization of consistent patterns of human immunodeficiency virus evolution within infected patients. , 2005, Molecular biology and evolution.

[20]  Z. Yang,et al.  Likelihood ratio tests for detecting positive selection and application to primate lysozyme evolution. , 1998, Molecular biology and evolution.

[21]  S. Muse,et al.  Site-to-site variation of synonymous substitution rates. , 2005, Molecular biology and evolution.

[22]  J. Goedert,et al.  HLA and HIV-1: heterozygote advantage and B*35-Cw*04 disadvantage. , 1999, Science.

[23]  S. Lawn,et al.  Contribution of Immune Activation to the Pathogenesis and Transmission of Human Immunodeficiency Virus Type 1 Infection , 2001, Clinical Microbiology Reviews.

[24]  R Blumenthal,et al.  Quantitation of human immunodeficiency virus type 1 infection kinetics , 1993, Journal of virology.

[25]  Lawrence Corey,et al.  Comprehensive Analysis of Human Immunodeficiency Virus Type 1 (HIV-1)-Specific Gamma Interferon-Secreting CD8+ T Cells in Primary HIV-1 Infection , 2003, Journal of Virology.

[26]  I. Thior,et al.  Reduced rate of disease development after HIV-2 infection as compared to HIV-1. , 1994, Science.

[27]  R. Nielsen,et al.  Effect of recombination on the accuracy of the likelihood method for detecting positive selection at amino acid sites. , 2003, Genetics.

[28]  Andrew Rambaut,et al.  Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies , 2000, Bioinform..

[29]  Todd M. Allen,et al.  HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.

[30]  J L Sullivan,et al.  Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. , 1995, The New England journal of medicine.

[31]  É. Oksenhendler,et al.  HIV-specific effector cytotoxic T lymphocytes and HIV-producing cells colocalize in white pulps and germinal centers from infected patients. , 2001, Blood.

[32]  A Esteves,et al.  Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. , 2001, AIDS research and human retroviruses.

[33]  David Posada,et al.  Recombination estimation under complex evolutionary models with the coalescent composite-likelihood method. , 2006, Molecular biology and evolution.

[34]  Allen G. Rodrigo,et al.  Immune-Mediated Positive Selection Drives Human Immunodeficiency Virus Type 1 Molecular Variation and Predicts Disease Duration , 2002, Journal of Virology.

[35]  D. Finzi,et al.  Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis , 2006, Clinical and Vaccine Immunology.

[36]  Robert D Holt,et al.  Linking Dynamical and Population Genetic Models of Persistent Viral Infection , 2003, The American Naturalist.

[37]  O. Pybus,et al.  Bayesian coalescent inference of past population dynamics from molecular sequences. , 2005, Molecular biology and evolution.

[38]  R. Nielsen,et al.  Likelihood models for detecting positively selected amino acid sites and applications to the HIV-1 envelope gene. , 1998, Genetics.

[39]  Daniel J. Wilson,et al.  Evolution of the Human Immunodeficiency Virus Envelope Gene Is Dominated by Purifying Selection , 2006, Genetics.

[40]  Sergei L. Kosakovsky Pond,et al.  Not so different after all: a comparison of methods for detecting amino acid sites under selection. , 2005, Molecular biology and evolution.

[41]  Helena Barroso,et al.  Phylogenetic demonstration of two cases of perinatal human immunodeficiency virus type 2 infection diagnosed in adulthood. , 2004, AIDS research and human retroviruses.

[42]  Alexei J Drummond,et al.  Estimating mutation parameters, population history and genealogy simultaneously from temporally spaced sequence data. , 2002, Genetics.

[43]  David L. Robertson,et al.  Comparative Study of Adaptive Molecular Evolution in Different Human Immunodeficiency Virus Groups and Subtypes , 2004, Journal of Virology.

[44]  Simon D W Frost,et al.  A simple hierarchical approach to modeling distributions of substitution rates. , 2005, Molecular biology and evolution.

[45]  Philip J. R. Goulder,et al.  HIV and SIV CTL escape: implications for vaccine design , 2004, Nature Reviews Immunology.

[46]  D. Richman,et al.  Rapid evolution of the neutralizing antibody response to HIV type 1 infection , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[47]  P. Fearnhead,et al.  A coalescent-based method for detecting and estimating recombination from gene sequences. , 2002, Genetics.

[48]  B. Korber,et al.  Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease , 1997, Journal of virology.

[49]  S. Coppens,et al.  Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. , 1999, AIDS research and human retroviruses.

[50]  J. Margolick,et al.  Consistent Viral Evolutionary Changes Associated with the Progression of Human Immunodeficiency Virus Type 1 Infection , 1999, Journal of Virology.

[51]  J. S. Sullivan,et al.  Genomic Structure of an Attenuated Quasi Species of HIV-1 from a Blood Transfusion Donor and Recipients , 1995, Science.

[52]  Martin A. Nowak,et al.  Causes of HIV diversity , 1995, Nature.

[53]  Bette Korber,et al.  HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity , 2004, AIDS.

[54]  J I Mullins,et al.  Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. , 2001, AIDS research and human retroviruses.

[55]  J K Kelly Replication rate and evolution in the human immunodeficiency virus. , 1996, Journal of theoretical biology.

[56]  Thomas C. Quinn,et al.  Neutralizing Antibodies Do Not Mediate Suppression of Human Immunodeficiency Virus Type 1 in Elite Suppressors or Selection of Plasma Virus Variants in Patients on Highly Active Antiretroviral Therapy , 2006, Journal of Virology.

[57]  Sergei L. Kosakovsky Pond,et al.  HyPhy: hypothesis testing using phylogenies , 2005, Bioinform..

[58]  Jan Albert,et al.  Evolution of human immunodeficiency virus type 2 coreceptor usage, autologous neutralization, envelope sequence and glycosylation. , 2005, The Journal of general virology.

[59]  Rafael Sanjuán,et al.  The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[60]  S. Frost,et al.  Genetic drift and within-host metapopulation dynamics of HIV-1 infection , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[61]  S. Ray,et al.  Convergent evolution within the V3 loop domain of human immunodeficiency virus type 1 in association with disease progression , 1995, Journal of virology.

[62]  H. Whittle,et al.  Maternal plasma viral RNA levels determine marked differences in mother-to-child transmission rates of HIV-1 and HIV-2 in The Gambia. MRC/Gambia Government/University College London Medical School working group on mother-child transmission of HIV. , 2000, AIDS.

[63]  S. Williamson,et al.  Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. , 2003, Molecular biology and evolution.

[64]  Guido Silvestri,et al.  Turnover of lymphocytes and conceptual paradigms in HIV infection. , 2003, The Journal of clinical investigation.

[65]  Yang Liu,et al.  Neutralizing antibody responses drive the evolution of human immunodeficiency virus type 1 envelope during recent HIV infection. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[66]  Hanneke Schuitemaker,et al.  In vitro replication capacity of HIV-2 variants from long-term aviremic individuals. , 2006, Virology.

[67]  John L. Sullivan,et al.  Absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection , 1995 .